Companies About Us Information News Customer Support Location Contact Us

Biotech ventures need a specialized work and support environment
for optimal development toward commercialization.

This is the premise and purpose of Technology Enterprise Park, located in Midtown Atlanta. The hub of Atlanta�s fast-growing biotech industry, Technology Enterprise Park serves corporations pushing new frontiers of life science and is affiliated with Georgia Tech, one of the nation�s top academic institutions in technology commercialization.
News & events>
St. Jude to acquire CardioMEMS following FDA approval of device, Reuters. In September 2010, St. Jude paid $60 million for a 19 percent stake in CardioMEMS, with an exclusive option to buy the remaining 81 percent for $375 million. The company said it plans to exercise its option and expects to complete the acquisition in the second quarter of this year.
Wireless Heart Monitor Fine-Tunes Cardiac-Failure Treatment, Scientific American. For the 5.8 million people in the U.S. faced with chronic heart failure, trips back to the hospital can be frequent, costly and dangerous. This new implanted electromechanical pressure sensor reduced hospital readmissions by 30 percent.
Global Center for Medical Innovation launches, Atlanta Journal Constitution, Atlanta Business Chronicle. The center will be housed at Technology Enterprise Park, alongside Georgia Tech. Gov. Sonny Perdue unveiled the plans this afternoon at the huge � and hugely important to Georgia � 2009 BIO International Convention at the Georgia World Congress Center.
Kemira consolidates North American R&D in Technology Enterprise Park, Atlanta Journal Constitution.  The Finnish company, which develops technologies for pulp and paper, water treatment and other industries, currently has six locations in Georgia and more than 100 worldwide. The company will move 85 jobs into 37,000 SF in Midtown Atlanta.



Copyright 2008 VLP3, LLC           

 Legal and Privacy              Home                    Mobile